Re Aurora (ACB)Was reading article about Aurora. Not sure if it has anything to do with LABS position in medical cannabinoids.
"The net cash position gives us the opportunity to do M&A," CEO Miguel Martin told Reuters. The company will likely focus on acquiring medical assets or medical infrastructure -- "something that's additive to medical would be more interesting to us than maybe others." In its earnings release on Thursday, Aurora said it has about $310-million of cash, including $65-million of restricted cash, as of Wednesday."